Pan-cancer

Quest Advanced™ solid tumor solutions combine state-of-the-art solid tumor genetic sequencing with powerful data analysis to provide a wide range of highly personalized information to help inform diagnosis and treatment.

• A broad oncology test menu available, including pan-tumor and cancer-specific panels
• Comprehensive health plan coverage to help reduce patient financial responsibility
• Easy access to Quest oncology experts for consultation and results interpretation

• Block retrieval program for when the sample is not on hand
• Prior authorization and patient financial assistance programs available
• Dedicated customer service team available at 1.833.773.1441

The Solid Tumor Expanded panel provides a full molecular tumor profile that includes 500+ genes associated with a broad spectrum of cancers. These insights can help guide therapy selection and likely expand the pool of potential clinical trials.

Quest offers the 49-gene Solid Tumor Core Panel to help physicians choose the most appropriate therapy for their patients based on the mutations found in the individual’s tumor sample DNA.